Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California University of California Davis Comprehensive Cancer Center, Sacramento, California University of Oklahoma, Oklahoma City, Oklahoma